Subscribe Premium

Biosimilars

Get Latest News, Breaking News about Biosimilars. Stay connected to all updated on Biosimilars

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

1 Dec 2022 11:07 AM IST

Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s Approval To Biosimilars

Patent Battle Over Breast Cancer Drug: Roche Withdraws Its SLP Against Delhi High Court’s Approval To Biosimilars

13 Aug 2017 11:25 AM IST